Related Experiment Video
Updated: Mar 2, 2026
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[The role of inflammatory biomarkers in cardiovascular risk stratification]
1ДЗ ЗАПОРІЗЬКА МЕДИЧНА АКАДЕМІЯ ПІСЛЯДИПЛОМНОЇ ОСВІТИ МОЗ УКРАЇНИ, ЗАПОРІЖЖЯ, УКРАЇНА.
Insights
Biomarkers of vascular inflammation, such as lipoprotein-associated phospholipase A2 (LP-PLA2) and soluble B-type natriuretic peptide (SB), help predict cardiovascular events. These markers improve risk assessment beyond traditional factors, aiding in preventing heart and brain disorders.
Area of Science:
- Cardiology
- Biomarker Research
- Vascular Inflammation
Background:
- Rising cardiovascular diseases necessitate novel prediction methods beyond traditional risk factors.
- Understanding the mechanisms of cardiovascular complications is crucial for developing new treatments.
Purpose of the Study:
- To investigate the link between vascular inflammation, atherosclerosis, and cardiovascular outcomes.
- To explore the role of inflammation biomarkers in predicting cardiovascular events.
Main Methods:
- Systematic literature review and bibliographic analysis.
- Focus on risk estimation for cardiovascular diseases using vascular inflammation biomarkers.
Main Results:
- Cardiovascular risk stratification algorithms incorporate traditional factors for preventive therapy.
- Cardiovascular events like myocardial infarction and stroke occur even in asymptomatic patients with normal lipids.
- Additional risk factors, including inflammation biomarkers (SB and LP-PLA2), aid in predicting cerebral and cardiac disorders and preventing mortality.
- Inflammation biomarkers are independent predictors of cardiovascular disease, distinct from traditional risk factors.
Conclusions:
- Lipoprotein-associated phospholipase A2 (LP-PLA2) and soluble B-type natriuretic peptide (SB) biomarkers are specific to vascular inflammation.
- These biomarkers establish a connection between endovascular inflammation, atherosclerosis progression, and cardiovascular disease.
- Utilizing these biomarkers aids in preventing cerebral and cardiac disorders, especially in patients with existing traditional risk factors.
Introduction:
The increase in cardiovascular diseases requires the search for ways to predict complications based on research additional to traditional risk factors, conduct a study of the formation mechanisms of these complications and to design new treatment strategies.
Aim:
To get an idea about the relationship between inflammation in the blood vessels, atherosclerosis and cardiovascular consequences based on the study of the role of biomarkers of inflammation.
Material And Methods:
the literature on the estimation of risk development of cardiovascular diseases based on the study of the role of biomarkers of vascular inflammation; bibliographic, a systematic approach.
Results:
Algorithm stratification of cardiovascular risk includes a review of the traditional risk factors for the purpose of preventive therapy. A large number of cases of cardiovascular events (myocardial infarction, stroke) occurs in bessimptomnom patients with normal lipid. The use of additional risk factors for development of cerebral and cardiac disorders will allow to foresee the consequences and to prevent mortality from cardiovascular disease. Study of the role of inflammation in development of cardiovascular diseases allows the use of SB and PL-ФЛА2 as an important additional cardiovascular markers, independent of traditional risk factors.
Conclusions:
The use of biomarkers LP-ФЛА2 and SB specific to vascular inflammation, allows to establish the relationship between endovascular inflammation, atherosclerosis development and progression of cardiovascular diseases and to prevent cerebral and cardiac disorders in patients with traditional risk factor .
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Coronary Artery Disease I: Introduction
01:38Inflammation
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:26Atherosclerosis III: Management